Article Information
History
- April 12, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Mitsuru Sasaki-Honda1,
- Tatsuya Jonouchi1,
- Meni Arai1,
- Junjie He1,
- Kazusa Okita2,
- Satoko Sakurai2,
- Takuya Yamamoto3 and
- Hidetoshi Sakurai4,*
- 1Department of Clinical Application, CiRA, Kyoto University, Kyoto 606-8507, Japan
- 2Department of Life Science Frontiers, CiRA, Kyoto University, Kyoto 606-8507, Japan
- 3Department of Life Science Frontiers, CiRA, Kyoto University, Kyoto 606-8507, Japan; Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Kyoto 606-8501, Japan; Medical Risk Avoidance Based on iPS Cells Team, RIKEN Center for Advanced Intelligence Projects (AIP), Kyoto 606-8507, Japan
- 4Department of Clinical Application, CiRA, Kyoto University, Kyoto 606-8507, Japan; Takeda-CiRA Joint Program, Fujisawa, Kanagawa 251-8555, Japan
- ↵*Corresponding author: Hidetoshi Sakurai, M.D., Ph.D., Center for iPS Cell Research and Application (CiRA), Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan. Telephone: 81-75-366-7055; E-Mail: hsakurai{at}cira.kyoto-u.ac.jp